MedPath

Calcitonin gene-related peptide

Generic Name
Calcitonin gene-related peptide
Drug Type
Biotech
CAS Number
83652-28-2
Unique Ingredient Identifier
JHB2QIZ69Z
Background

A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.

As a potential drug, it has demonstrated in preclinical studies a profile that could make it an ideal anti-asthmatic drug candidate with bronchodilatory, bronchoprotecting and anti-inflammatory properties.

Indication

Investigated for use/treatment in myocardial infarction, heart disease, and asthma.

Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.

Not Applicable
Completed
Conditions
Familial Hemiplegic Migraine
First Posted Date
2006-08-01
Last Posted Date
2006-11-10
Lead Sponsor
Danish Headache Center
Target Recruit Count
20
Registration Number
NCT00358839
Locations
🇩🇰

Danish Headache Center, Glostrup, Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath